NEW YORK – (BUSINESS WIRE) – According to Prevention Magazine’s 13th annual national survey Consumer Reaction to DTC Advertising of Prescription Drugs, consumers are paying attention to the FDA regulated “fair balance” mandate between risk and benefit information on all DTC ads; the majority believe pharmaceutical advertising in magazines and television is presented “both fair and balanced.”
Please don”t hold the Mayo
One of the more interesting subtexts surrounding King James” move to Miami is the negative economic impact it will have on the economy of Cleveland specifically and Ohio in general.
A similar subtext (albeit one that has been entirely ignored) is the negative economic impact the State of Michigan will experience following the University of Michigan”s recent announcement that it will ban any industry-sponsored CME.
The following was written by Peter Pitts, blogger at . Comments are encouraged.
Once more into the abyss.
The Accreditation Council for Continuing Medical Education (ACCME), the national body that accredits medical education courses, has decided that physicians and researchers who work inside the pharmaceutical industry will not be allowed to make medical education presentations at medical meetings.
Thanks to Tom Sullivan for providing this roundup of information on current issues that affect the healthcare communication industry. For more of Tom”s commentary and analysis, visit his blog at www.policymed.com
A study by the Cleveland Clinic’s Center for Continuing Education showed that there was no correlation between the perception of bias and the commercial support status of an activity such as continuing medical education.
Comments are welcome here.flagyl generic walmart
The Coalition and Med Ad News are collaborating on a series of podcasts by John Kamp, Coalition Executive Director, on topics vital to the healthcare communication industry. The 4th podcast, “Approach with Caution,” is now available for download. In this segment, Mr. Kamp talks about social media, why legal departments will continue to voice strong resistance to going too far and he also acknowledges the great opportunity social media hold in improving the industry relationship and reputation with consumers.
All 4 podcasts can be downloaded here: prednisone for sale
On June 21, 2007, U.S. Representative Pete Stark introduced a bill titled the “Fair Balance Prescription Drug Advertisement Act of 2007.” H.R. 2823 (110th Cong., 1st Sess.). If enacted, the bill would deny a tax deduction for any expenses associated with a direct-to-consumer (“DTC”) advertisement for a new prescription drug for the first 2 years after approval.
You can visit to download podcasts on healthcare issues by John Kamp, the Coalition”s Executive Director.
The 1st is on the defeated but still looming ad tax bill. The 2nd is an overview and analysis of the “New FDA.”
Med Ad News plans to present 3 more podcasts in this series.bayer cipro prostatitis
The February issue of MM&M magazine spotlights Policymed.com blogger Tom Sullivan.
Continuing his “ongoing probe into conflicts of interest,” Senator Chuck Grassley this week sent letters to the American Medical Association, Alzheimer’s Association, the American Cancer Society and 30 other disease and medical advocacy organizations asking them to provide details about the amount of money that they and their directors receive from drug and device makers.
Read more, including Senator Grassley’s letter, in Thomas Sullivan’s Policy and Medicine Blog.